S&Co Inc Gilead Sciences, Inc. Transaction History

S&Co Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$57.92 - $72.58 $472,048 - $591,527	-8,150 Closed	0 $0
Q2 2021 Jul 14, 2021	BUY	$63.47 - $69.35 $44,429 - $48,544	700 Added 9.4%	8,150 $561,000
Q1 2021 Apr 23, 2021	BUY	$60.0 - $68.46 $54,000 - $61,613	900 Added 13.74%	7,450 $481,000
Q2 2020 Dec 16, 2020	SELL	$72.34 - $84.0 $42,680 - $49,560	-590 Reduced 8.26%	6,550 $504,000
Q1 2020 Apr 28, 2020	BUY	$62.63 - $80.22 $5,636 - $7,219	90 Added 1.28%	7,140 $534,000
Q4 2019 Jan 24, 2020	BUY	$61.62 - $67.78 $6,162 - $6,778	100 Added 1.44%	7,050 $458,000
Q3 2019 Oct 29, 2019	BUY	$62.51 - $69.0 $20,315 - $22,425	325 Added 4.91%	6,950 $440,000
Q2 2019 Jul 23, 2019	BUY	$61.87 - $69.38 $14,539 - $16,304	235 Added 3.68%	6,625 $448,000
Q1 2019 Apr 24, 2019	BUY	$62.53 - $70.05 $4,064 - $4,553	65 Added 1.03%	6,390 $415,000
Q4 2018 Jan 29, 2019	BUY	$60.54 - $79.0 $19,978 - $26,070	330 Added 5.5%	6,325 $396,000
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $12,474 - $13,811	-175 Reduced 2.84%	5,995 $463,000
Q2 2018 Jul 27, 2018	SELL	$64.88 - $75.68 $103,743 - $121,012	-1,599 Reduced 20.58%	6,170 $437,000
Q1 2018 May 02, 2018	BUY	$72.84 - $88.8 $142,766 - $174,048	1,960 Added 33.74%	7,769 $586,000
Q4 2017 Jan 22, 2018	SELL	$71.15 - $83.52 $41,195 - $48,358	-579 Reduced 9.06%	5,809 $416,000
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $460,638 - $545,982	6,388	6,388 $518,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of S&Co Inc, based on Form 13F filings with the SEC.

Stay updated on S&Co Inc with notifications on news.